Content about Experimental drug

March 25, 2013
Lilly, BI apply for diabetes drug approval

Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said.

February 19, 2013
FDA grants priority review to ViiV drug for HIV

The Food and Drug Administration has granted priority review to an experimental drug made by ViiV Healthcare for HIV, the company, a joint venture between British drug maker GlaxoSmithKline and American drug maker Pfizer, announced.

February 14, 2013
Eisai receives orphan drug designation for thyroid cancer drug

The Food and Drug Administration has granted special designation to a drug made by Eisai for treating thyroid cancer.

January 30, 2013
FDA panel recommends approval for Boehringer Ingelheim COPD drug

A panel of Food and Drug Administration experts has recommended approval for an experimental drug made by Boehringer Ingelheim for chronic obstructive pulmonary disease, the drug maker said.

January 3, 2013
Experimental ALS drug fails in trial

An experimental drug for Lou Gehrig's disease made by Biogen Idec has failed in a late-stage clinical trial, the drug maker said.

December 12, 2012
FDA accepts application for Takeda, Lundbeck antidepressant

The Food and Drug Administration has accepted a regulatory approval application from Takeda and Lundbeck for an experimental drug to treat depression, the companies said Wednesday.

December 12, 2012
J&J subsidiary seeks approval for Type 2 diabetes drug

A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

November 8, 2012
FDA accepts Merck application for insomnia drug

The Food and Drug Administration has accepted an application from Merck for an experimental drug for insomnia, the drug maker said Thursday.

September 6, 2012
FDA advisory committee recommends approval for Novartis cystic fibrosis drug

A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.

May 29, 2012
FDA panel backs Pfizer drug for rare genetic disease

An experimental drug made by Pfizer for a rare and fatal neurodegenerative disease got a favorable vote from a Food and Drug Administration expert panel.

May 24, 2012
Bayer HealthCare submits approval application for colorectal cancer drug

Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.

April 30, 2012
Reports: Dying woman's plea prompts early release of cancer drug

An online plea for help from a mother dying of breast cancer prompted the manufacturer of an experimental drug to release it early, according to published reports.

April 26, 2012
FDA declines to approve Takeda diabetes drug

The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.

April 16, 2012
Merck, Endocyte sign deal to develop cancer drug

Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.

June 13, 2010
FDA advisory committee gives nod to investigational MS drug

An advisory committee of the Food and Drug Administration unanimously recommended approval for an investigational...

© 2013 Drug Store News. All Rights Reserved.